Key result
Dopamine receptor blockade reduces time-to-exhaustion ~29% vs placebo, while exogenous dopamine fails to improve tolerance.
Why the study?
Does exogenous dopamine or D2-receptor blockade alter pulmonary diffusing capacity, capillary blood volume, or exercise tolerance in healthy subjects during exercise?
RCT (n=14)
Randomly assigned
Does exogenous dopamine or D2-receptor blockade alter pulmonary diffusing capacity, capillary blood volume, or exercise tolerance in healthy subjects during exercise?
Absolute Event Rate: 259% vs 367%
p-value: p=<0.05
Endogenous dopamine appears important for maintaining exercise tolerance during heavy exertion, but exogenous dopamine does not enhance exercise tolerance or alter pulmonary diffusing capacity.
No takes yet. Share an insight, caveat, or question.
Dopamine blockade impairs heavy exercise tolerance; confirms endogenous dopamine necessity while challenging exogenous supplementation benefits.
Wade W. Michaelchuk (2017) conducted an RCT in Healthy (n=14). Intravenous dopamine or oral D2-receptor antagonist (metoclopramide) vs. Intravenous saline and placebo pill was evaluated on Time-to-exhaustion at 85% of VO2peak (p=<0.05). Dopamine receptor blockade significantly reduced time-to-exhaustion compared to placebo (259 vs 367 seconds; P<0.05), whereas exogenous dopamine did not improve exercise tolerance or pulmonary diffusing capacity.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: